Guangxi LiuYao Group Co Ltd
SSE:603368
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
G
|
Guangxi LiuYao Group Co Ltd
SSE:603368
|
7.2B CNY |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
101.7B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.3B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
64B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
49.4B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
36.6B AUD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.9B CNY |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.4B HKD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
Market Distribution
| Min | -409 046.1% |
| 30th Percentile | -1.4% |
| Median | 4.2% |
| 70th Percentile | 10.3% |
| Max | 876.4% |
Other Profitability Ratios
Guangxi LiuYao Group Co Ltd
Glance View
Guangxi LiuYao Group Co Ltd, nestled in the lush landscapes of southern China, draws its origin from the age-old traditions that define the region’s rich heritage. This company, renowned for its deep-rooted expertise, specializes in the production of traditional Chinese medicines and healthcare products. Utilizing a blend of modern technology and ancient wisdom, LiuYao crafts remedies that resonate with the holistic approach cherished in Eastern medicine. The company harnesses the abundant resources of Guangxi's natural surroundings, where access to a diverse array of medicinal plants and herbs aids in the development of potent formulations. By marrying these natural elements with advanced scientific research and development, Guangxi LiuYao stands out in the crowded pharmaceutical market, maintaining a legacy of trust and efficacy among its consumers. In the competitive arena of healthcare, Guangxi LiuYao Group Co Ltd has carved a niche through its robust distribution strategies and insightful marketing practices. Their business model intricately weaves together local understanding and international ambition, allowing them to penetrate both domestic and foreign markets effectively. Retail chains, pharmacies, and hospitals across China form the backbone of their distribution network, ensuring their products reach a broad demographic. Additionally, through strategic partnerships and exports, LiuYao aligns itself with global healthcare trends, exploring opportunities in regions appreciative of alternative medicine. This dual approach of leveraging heritage and embracing modern market dynamics fuels their revenue, positioning Guangxi LiuYao favorably within the evolving landscape of global healthcare enterprises.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Guangxi LiuYao Group Co Ltd is 5.3%, which is below its 3-year median of 5.9%.
Over the last 3 years, Guangxi LiuYao Group Co Ltd’s Operating Margin has decreased from 5.8% to 5.3%. During this period, it reached a low of 5.3% on Oct 30, 2025 and a high of 6.4% on Mar 31, 2024.